Tomohiro Takahashi

Suggest Changes
Learn More
It remains to be determined whether the evidence in Western countries for blockade of the renin–angiotensin System in cardiovascular diseases could be directly applied to East Asian races including(More)
We examined whether an additive treatment with an angiotensin receptor blocker, olmesartan, reduces the mortality and morbidity in hypertensive patients with chronic heart failure (CHF) treated with(More)